z-logo
Premium
Chronic intermittent hypoxia augments bleomycin induced lung fibrosis in rats (LB794)
Author(s) -
Braun Rudolf,
Broytman Oleg,
Pegelow David,
Hsu PeiNing,
Mei Linda,
Modi Dhruvangkumar,
Eldridge Marlowe,
Teodorescu Mihaela
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.lb794
Subject(s) - medicine , bleomycin , lung , pulmonary fibrosis , intermittent hypoxia , fibrosis , hypoxia (environmental) , pulmonary function testing , gastroenterology , saline , anesthesia , obstructive sleep apnea , chemistry , chemotherapy , organic chemistry , oxygen
Rationale: Obstructive sleep apnea (OSA) is common among patients with idiopatic pulmonary fibrosis (IPF), where it has been linked with increased mortality. Chronic intemittent hypoxia (CIH) _ its hallmark feature _ may be one culprit. We tested the effects of CIH exposure on lung collagen, gas exchange and lung function following intratracheal bleomycin instillation in rats. Methods: Four groups (n=4/group) of Sprague Dawley rats were instilled with bleomycin (1.5 U/kg) (BLEO) or saline (SAL). Five days after instillation, rats were subjected to CIH (10% FiO 2 , 30 episodes/h, 10h/day) vs. normoxia (NORM) for 30 days. Total collagen in the right lung, pO 2 and pCO 2 in the exhaled air, and lung function by body plethysmography were compared between groups. Results: CIH resulted in: 1) significant increase in total collagen in bleomycin injured lungs compared to BLEO/NORM or the SAL controls ( Figure 1 ); 2) significant exhaled O 2 abnormalities in both SAL and BLEO treated groups compared to the respective NORM groups ( Figure 2 ); 3) a trend of reduced FEV0.1/FVC ratio in CIH treated groups in both the BLEO and SAL compared to the NORM group (0.78±0.10 vs. 0.71±0.14 and 0.67±0.17 vs. 0.61±0.15). C onclusions: CIH aggravates lung fibrosis and gas exchange abnormalities following bleomycin. These findings underscore the potential of OSA to exacerbate IPF.Grant Funding Source : UW‐Madison Department of Medicine Pilot Funding

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom